Provided by Tiger Fintech (Singapore) Pte. Ltd.

MediWound

16.27
-0.7800-4.57%
Post-market: 16.270.00000.00%16:13 EDT
Volume:239.47K
Turnover:3.92M
Market Cap:175.55M
PE:-5.55
High:16.86
Open:16.86
Low:16.22
Close:17.05
Loading ...

Buy Rating for Mediwound Driven by EscharEx’s Market Potential and Disruptive Role in Chronic Wound Care

TIPRANKS
·
12 Jan

MediWound Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Jan

Buy Rating for Mediwound Driven by EscharEx’s Promising Market Potential and Revenue Growth

TIPRANKS
·
10 Jan

Mediwound (MDWD) Receives a Buy from TD Cowen

TIPRANKS
·
09 Jan

Mediwound Advances in Enzymatic Therapeutics with Strategic Expansions

TIPRANKS
·
08 Jan

MediWound Approves 2024 Share Incentive Plan to Boost Employee Engagement

TIPRANKS
·
20 Dec 2024

MediWound to host virtual KOL event to discuss EscharEx Phase III VALUE study

TIPRANKS
·
17 Dec 2024

MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025

GlobeNewswire
·
17 Dec 2024

MediWound Executives Acquire 18,462 Shares, Signaling Confidence in Company’s Future

TIPRANKS
·
16 Dec 2024

MediWound Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
27 Nov 2024

MediWound Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
27 Nov 2024

MediWound Ltd (MDWD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

GuruFocus.com
·
27 Nov 2024

MediWound Advances Enzymatic Therapeutics Amid Financial Shifts

TIPRANKS
·
27 Nov 2024

Mediwound’s Promising Outlook: Expansion and Trials Support Buy Rating

TIPRANKS
·
27 Nov 2024

Mediwound Ltd reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
26 Nov 2024

MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
26 Nov 2024